{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:17:23Z","timestamp":1792790243394,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"am","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejso.2022.01.016","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T18:04:56Z","timestamp":1643825096000},"page":"1375-1383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["BRAF V600E mutations in right-side colon cancer: Heterogeneity detected by liquid biopsy"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7423-5150","authenticated-orcid":false,"given":"Koji","family":"Ueda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1436-7482","authenticated-orcid":false,"given":"Takeshi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2627-2859","authenticated-orcid":false,"given":"Ryo","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9791-7741","authenticated-orcid":false,"given":"Hiromichi","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7055-8032","authenticated-orcid":false,"given":"Sho","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4706-1228","authenticated-orcid":false,"given":"Takuma","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohki","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4066-0479","authenticated-orcid":false,"given":"Toshimitsu","family":"Miyasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9204-6393","authenticated-orcid":false,"given":"Seiichi","family":"Shinji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6566-6714","authenticated-orcid":false,"given":"Noriyasu","family":"Chika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2022.01.016_bib1","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1078-0432.CCR-11-2246","article-title":"Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803","volume":"18","author":"Ogino","year":"2012","journal-title":"Clin Cancer Res : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.ejso.2022.01.016_bib2","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jamaoncol.2016.5469","article-title":"Association of DNA mismatch repair and mutations in BRAF and KRAS with survival after recurrence in stage III colon cancers : a secondary analysis of 2 randomized clinical trials","volume":"3","author":"Sinicrope","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejso.2022.01.016_bib3","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S1470-2045(15)00122-9","article-title":"FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study","volume":"16","author":"Cremolini","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2022.01.016_bib4","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S1470-2045(14)70330-4","article-title":"FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial","volume":"15","author":"Heinemann","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2022.01.016_bib5","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1002\/cncr.26086","article-title":"Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer","volume":"117","author":"Tran","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2022.01.016_bib6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/bjc.2011.19","article-title":"BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer","volume":"104","author":"Yokota","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2022.01.016_bib7","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/bjc.2017.308","volume":"117","author":"Shinozaki","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2022.01.016_bib8","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1158\/1078-0432.CCR-17-2484","article-title":"Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and consensus molecular subtypes","volume":"24","author":"Loree","year":"2018","journal-title":"Clin Cancer Res : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.ejso.2022.01.016_bib9","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/ijc.32320","article-title":"Non-V600E BRAF mutations and EGFR signaling pathway in colorectal cancer","volume":"145","author":"Osumi","year":"2019","journal-title":"International journal of cancer Journal international du cancer"},{"key":"10.1016\/j.ejso.2022.01.016_bib10","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/annonc\/mdx119","article-title":"Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies","volume":"28","author":"Boeckx","year":"2017","journal-title":"Ann Oncol : official journal of the European Society for Medical Oncology \/ ESMO"},{"key":"10.1016\/j.ejso.2022.01.016_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejso.2022.01.016_bib12","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.molonc.2014.06.005","article-title":"Tumour heterogeneity and the evolution of polyclonal drug resistance","volume":"8","author":"Burrell","year":"2014","journal-title":"Molecular oncology"},{"key":"10.1016\/j.ejso.2022.01.016_bib13","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/cas.12959","article-title":"Utility of KRAS mutation detection using circulating cell-free DNA from patients with colorectal cancer","volume":"107","author":"Yamada","year":"2016","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejso.2022.01.016_bib14","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/annonc\/mdx112","article-title":"Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer","volume":"28","author":"Grasselli","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2022.01.016_bib15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/1878-0261.12023","article-title":"Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing","volume":"11","author":"Schmiegel","year":"2017","journal-title":"Molecular oncology"},{"key":"10.1016\/j.ejso.2022.01.016_bib16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.ejso.2018.01.224","article-title":"Evaluation of liquid biopsies for detection of emerging mutated genes in metastatic colorectal cancer","volume":"44","author":"Furuki","year":"2018","journal-title":"Eur J Surg Oncol : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"key":"10.1016\/j.ejso.2022.01.016_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000494411","article-title":"Liquid biopsy for the management of patients with colorectal cancer","volume":"99","author":"Yamada","year":"2019","journal-title":"Digestion"},{"key":"10.1016\/j.ejso.2022.01.016_bib18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1245\/s10434-017-6300-x","article-title":"Oncological assessment of stent placement for obstructive colorectal cancer from circulating cell-free DNA and circulating tumor DNA dynamics","volume":"25","author":"Takahashi","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.016_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.3755","article-title":"Methylation status and long-fragment cell-free DNA are prognostic biomarkers for gastric cancer","author":"Ko","year":"2021","journal-title":"Cancer medicine"},{"key":"10.1016\/j.ejso.2022.01.016_bib20","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s10147-020-01691-0","article-title":"Emerging RAS, BRAF, and EGFR mutations in cell-free DNA of metastatic colorectal patients are associated with both primary and secondary resistance to first-line anti-EGFR therapy","volume":"25","author":"Yamada","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ejso.2022.01.016_bib21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejso.2019.08.010","article-title":"Circulating cell-free long DNA fragments predict post-hepatectomy recurrence of colorectal liver metastases","volume":"46","author":"Iwai","year":"2020","journal-title":"Eur J Surg Oncol : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"key":"10.1016\/j.ejso.2022.01.016_bib22","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1111\/cas.14186","article-title":"Analysis of colorectal cancer-related mutations by liquid biopsy: utility of circulating cell-free DNA and circulating tumor cells","volume":"110","author":"Takeda","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejso.2022.01.016_bib23","volume":"107","author":"Yoon","year":"2015"},{"key":"10.1016\/j.ejso.2022.01.016_bib24","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/cas.14389","article-title":"Genomic landscape of metastatic papillary thyroid carcinoma and novel biomarkers for predicting distant metastasis","volume":"111","author":"Lan","year":"2020","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejso.2022.01.016_bib25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1470-2045(20)30726-9","article-title":"Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study","volume":"22","author":"Syeda","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2022.01.016_bib26","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1158\/1078-0432.CCR-20-1037","article-title":"Circulating tumor DNA genomics reveal potential mechanisms of resistance to BRAF-targeted therapies in patients with BRAF-mutant metastatic non-small cell lung cancer","volume":"26","author":"Ortiz-Cuaran","year":"2020","journal-title":"Clin Cancer Res : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.ejso.2022.01.016_bib27","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.1093\/nar\/gkq421","article-title":"Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts","volume":"38","author":"Thierry","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ejso.2022.01.016_bib28","article-title":"Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing","volume":"15","author":"Kang","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ejso.2022.01.016_bib29","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1515\/cclm-2019-0142","article-title":"Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients","volume":"57","author":"Wang","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ejso.2022.01.016_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cells8060516","article-title":"Circulating tumor cells and circulating tumor DNA detection in potentially resectable metastatic colorectal cancer: a prospective ancillary study to the unicancer prodige-14 trial","volume":"8","author":"Bidard","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ejso.2022.01.016_bib31","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJMoa1908075","article-title":"Encorafenib, binimetinib, and cetuximab in BRAF V600e-mutated colorectal cancer","volume":"381","author":"Kopetz","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2022.01.016_bib32","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/annonc\/mdv176","article-title":"Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial","volume":"26","author":"Normanno","year":"2015","journal-title":"Ann Oncol : official journal of the European Society for Medical Oncology \/ ESMO."},{"key":"10.1016\/j.ejso.2022.01.016_bib33","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41591-019-0561-9","article-title":"Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers","volume":"25","author":"Parikh","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2022.01.016_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2021.07.017","article-title":"Detection of KRAS mutations in circulating tumour DNA from plasma and urine of patients with colorectal cancer","author":"Ohta","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"21","key":"10.1016\/j.ejso.2022.01.016_bib35","first-page":"94","article-title":"Evaluating mismatch repair deficiency for solid tumor immunotherapy eligibility: immunohistochemistry versus microsatellite molecular testing","volume":"S0046\u20138177","author":"Saeed","year":"2021","journal-title":"Hum Pathol"},{"issue":"35","key":"10.1016\/j.ejso.2022.01.016_bib36","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1200\/JCO.2008.17.5950","article-title":"Feasibility of screening for Lynch syndrome among patients with colorectal cancer","volume":"26","author":"Hampel","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.01.016_bib37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1158\/1940-6207.CAPR-11-0288","article-title":"Identification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing","volume":"5","author":"Bartley","year":"2012","journal-title":"Cancer Prev Res"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322000427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322000427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:41:40Z","timestamp":1760060500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322000427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0748798322000427"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.01.016","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BRAF V600E mutations in right-side colon cancer: Heterogeneity detected by liquid biopsy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}